Ken Griffin acquired 29 Thousand Ultragenyx Pharmaceutical shares worth $1.04 Million. That's 0.00% of their equity portfolio (2820th largest holding). The first Ultragenyx Pharmaceutical trade was made in Q1 2014. Since then Ken Griffin bought shares 54 more times and sold shares on 52 occasions. The investor's estimated purchase price is $1.6 Million, resulting in a loss of 35%.